Wow, biotech ICOs looks trendy nowadays. Just participated in Shivom ICO, it was completely sold out in 8 minutes! it seems to me that you guys have all the chances to raise funds.
Moreover your project is not about money, it has real value and can change our lives to the better!
One key difference though is that they do not actually perform biomedical research. They are only developing the software solution, while we perform actual AIDS cure research. The implications are substantial as it means our Token utility is directly related to our research.
Yeah, that's right. You have real utility token. And I have never met before any ICO devoted to AIDS cure research. And you bring value to the people.
If I have some tokens, what can you provide me in your platform?
First, in addition to what we can provide you in our platform, you will hold a Token that is backed by the value of actual physical goods. So you know that you hold something that has some actual real world value. The reason is that we wanted our Token to also succeed as crypto used as a means of payment for goods and services. Yes, we were that ambitious.
•At the first stage (right after the end of the Token Sale) we will launch our INNBC JDM ONLINE GARAGE, were INNBC tokens can be spent to buy cars from a selection of high quality JDM classic cars. Selection of cars will mostly concentrate on classic iconic JDM cars such as Skylines, Supras, Subaru, and EVOs. Wonderfully, when it comes to JDM cars, our founder, Jonathan Fior, has a great expertise as he is personally involved in the business of importing them and over the years he has therefore established a solid network of professional contacts, which makes us confident about providing a quality service.
We also did this because we wanted to protect INNBC Token holders from the highly speculative nature of trading prices on crypto exchanges by having our Token backed by the value of actual physical goods; these classic JDM cars are true collector items and as such they are only going up in value.
Now, to specifically answer your question, let's talk about the Token utility within our platform.
•At the second stage (3-6 months after Token sale) we will launch the first version of our “You’re not alone” app, were INNBC tokens can be spent to access a number of privileged features in the app ecosystem such as becoming moderator in the social communities. The 1% of the revenue generated by in-app ads will go to community moderators as a compensation for their work. So you will be able to use our Token to become moderator, and once you have such a position, you will earn actual money from in-app ads as a compensation for your work.
In addition, Token economy will be integral part of the rep reward point system of the social community. Users who will make particularly useful contributions will earn Tokens. As an incentive to make the community grow, which in turn means more revenue from in app-ads, and thus more earings for moderators.
Now, what is the main factor that will drive the user adoption of our app, which in turn will make the community grow, meaning more revenue from in app-ads?
Our AIDS cure research. HIV seropositive people (and anyone who is just interested about AIDS research) will join the community to be updated about the state of our research, to open topics discussing the research, and for receiving information and support by our staff that will manage the platform. In conclusion, our AIDS research will be integral to the utilty and therefore value of INNBC Tokens.
In addition, we plan to accept INNBC Tokens as a means of payment for all our future medical treatments and products.
The "you're not alone" app will also feature a decentralized database for processing clinical data. We will start using the app for our own research, which means any user will be able to download the app and have a representation of all the data on the fly. Something that current ancient databases cannot provide. And it is likely that our app will also be used by other research institutions as we believe that it will help speed up clinical research development tremendously.
